Table 1 Baseline characteristics of individuals stratified by tertiles of apo B/apo A1 ratio
From: Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients
Variables | Apo B/Apo A1 Ratio Tertiles | Total | P Value | ||
|---|---|---|---|---|---|
≤0.545 (n = 285) | 0.545 − 0.769 (n = 285) | >0.769 (n = 290) | |||
Age (yr) | 50.9 ± 14.8 | 48.7 ± 14.3 | 50.0 ± 14.5 | 49.9 ± 14.5 | 0.200 |
Men (%) | 164 (57.5) | 172 (60.4) | 159 (54.8) | 495 (57.6) | 0.408 |
Body mass index (kg/m2) | 21.0 ± 3.2 | 22.2 ± 3.5 | 22.6 ± 3.4 | 21.9 ± 3.4 | < 0.001 |
Diabetes (%) | 46 (16.1) | 50 (17.5) | 70 (24.1) | 166 (19.3) | 0.034 |
CVD (%) | 25 (8.8) | 25 (8.8) | 37 (12.8) | 87 (10.1) | 0.186 |
Systolic pressure (mmHg) | 145 ± 27 | 148 ± 26 | 147 ± 26 | 147 ± 26 | 0.541 |
Diastolic pressure (mmHg) | 87 ± 17 | 90 ± 15 | 88 ± 15 | 87 ± 17 | 0.067 |
Total Kt/V | 2.01 (1.43, 2.53) | 2.26 (1.79, 2.69) | 2.23 (1.81, 2.80) | 2.18 (1.68, 2.70) | < 0.001 |
eGFR (ml/min per 1.73 m2) | 2.66 (1.54, 4.09) | 3.59 (2.02, 5.82) | 3.85 (1.89, 6.07) | 3.26 (1.78, 5.56) | < 0.001 |
Hemoglobin (g/L) | 76.65 ± 16.48 | 79.71 ± 16.19 | 80.74 ± 16.75 | 79.04 ± 16.55 | 0.009 |
N/L | 3.27 (2.37, 4.75) | 3.50 (2.53, 5.53) | 3.86 (2.61, 5.20) | 3.58 (2.50, 5.12) | 0.028 |
Albumin (g/L) | 35.90 ± 5.00 | 35.70 ± 5.31 | 34.50 ± 5.29 | 35.36 ± 5.23 | 0.848 |
Total cholesterol (mmol/L) | 3.56 (3.05, 4.30) | 4.03 (3.46, 4.80) | 4.55 (3.84, 5.40) | 4.06 (3.34, 4.89) | < 0.001 |
Triglyceride (mmol/L) | 1.00 (0.73, 1.36) | 1.27 (0.91, 1.72) | 1.68 (1.14, 2.21) | 1.28 (0.89, 1.78) | < 0.001 |
Low density lipoprotein (mmol/L) | 1.90 (1.40, 2.30) | 2.31 (1.89, 2.93) | 2.81 (2.24, 3.46) | 2.30 (1.83, 2.94) | < 0.001 |
High density lipoprotein (mmol/L) | 1.20 (0.96, 1.53) | 1.14 (0.92, 1.42) | 0.98 (0.81, 1.16) | 1.08 (0.89, 1.37) | < 0.001 |
Apo B (g/L) | 0.60 (0.50, 0.70) | 0.80 (0.70, 0.90) | 1.07 (0.90, 1.41) | 0.80 (0.63, 1.00) | < 0.001 |
Apo A1 (g/L) | 1.38 (1.22, 1.59) | 1.23 (1.10, 1.40) | 1.09 (0.98, 1.23) | 1.22 (1.07, 1.41) | < 0.001 |
Lipoprotein (a) (mg/L) | 284 (141, 514) | 303 (160, 501) | 409 (226, 663) | 328 (172, 586) | < 0.001 |
Lipid-lowering agents use (%) | 29 (10.2) | 36(12.6) | 24(8.3) | 89(10.3) | 0.228 |